Mizuho Securities USA LLC Has $2.09 Million Stock Position in Waters Co. (NYSE:WAT)

Mizuho Securities USA LLC raised its position in shares of Waters Co. (NYSE:WAT) by 46.2% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 5,627 shares of the medical instruments supplier’s stock after purchasing an additional 1,778 shares during the quarter. Mizuho Securities USA LLC’s holdings in Waters were worth $2,088,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in the company. Bank of Jackson Hole Trust bought a new stake in Waters during the fourth quarter valued at $34,000. Fortitude Family Office LLC boosted its position in shares of Waters by 235.7% during the 4th quarter. Fortitude Family Office LLC now owns 94 shares of the medical instruments supplier’s stock valued at $35,000 after purchasing an additional 66 shares in the last quarter. Steward Partners Investment Advisory LLC grew its stake in Waters by 129.3% during the fourth quarter. Steward Partners Investment Advisory LLC now owns 94 shares of the medical instruments supplier’s stock worth $35,000 after purchasing an additional 53 shares during the period. EverSource Wealth Advisors LLC increased its holdings in Waters by 54.3% in the fourth quarter. EverSource Wealth Advisors LLC now owns 125 shares of the medical instruments supplier’s stock worth $46,000 after purchasing an additional 44 shares in the last quarter. Finally, R Squared Ltd acquired a new position in Waters in the fourth quarter valued at approximately $63,000. Institutional investors own 94.01% of the company’s stock.

Wall Street Analysts Forecast Growth

WAT has been the subject of several research analyst reports. Bank of America lowered their price objective on shares of Waters from $430.00 to $410.00 and set a “neutral” rating for the company in a research note on Thursday, February 13th. UBS Group upped their price objective on shares of Waters from $405.00 to $410.00 and gave the company a “neutral” rating in a report on Thursday, February 13th. Barclays raised Waters from an “underweight” rating to an “equal weight” rating and boosted their target price for the company from $360.00 to $415.00 in a research report on Monday, February 10th. StockNews.com cut Waters from a “buy” rating to a “hold” rating in a research note on Tuesday, February 25th. Finally, Wells Fargo & Company upped their target price on Waters from $415.00 to $420.00 and gave the stock an “overweight” rating in a research report on Thursday, February 13th. Eleven research analysts have rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, Waters has an average rating of “Hold” and an average price target of $391.07.

Waters Trading Up 2.1 %

Shares of WAT stock opened at $373.07 on Tuesday. Waters Co. has a 52-week low of $279.24 and a 52-week high of $423.56. The company has a 50-day simple moving average of $390.29 and a two-hundred day simple moving average of $371.85. The company has a debt-to-equity ratio of 1.14, a quick ratio of 0.65 and a current ratio of 0.94. The company has a market capitalization of $22.16 billion, a price-to-earnings ratio of 34.83, a PEG ratio of 3.79 and a beta of 1.00.

Waters (NYSE:WAT) last issued its quarterly earnings results on Wednesday, February 12th. The medical instruments supplier reported $4.10 EPS for the quarter, beating analysts’ consensus estimates of $4.02 by $0.08. Waters had a return on equity of 46.31% and a net margin of 21.56%. Research analysts anticipate that Waters Co. will post 12.86 EPS for the current fiscal year.

Waters Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.